Acura Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Acura Pharmaceuticals, Inc.
Quantité totale PI 40
Rang # Quantité totale PI 35 893
Note d'activité PI 1,8/5.0    9
Rang # Activité PI 101 981
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

19 4
3 2
12 0
0
 
Dernier brevet 2024 - Methods and compositions for sel...
Premier brevet 2003 - Process for manufacturing thebaine
Dernière marque 2014 - OXAYDO
Première marque 2004 - ACURA PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Methods and compositions for self-regulated release of active pharmaceutical ingredient. An abus...
Invention Methods and compositions for interfering with extraction or conversion of a drug susceptible to a...
2022 Invention Methods and compositions for self-regulated release of active pharmaceutical ingredients. An abu...
2021 Invention Methods and compositions for self-regulated release of active pharmaceutical ingredient. An abuse...
2020 Invention Abuse deterrent compositions and methods of making same. This invention relates a therapeutic ph...
2018 Invention Methods and compositions for self-regulated release of active pharmaceutical ingredients. An abus...
Invention Methods and compositions for self-regulated release of active pharmaceuticals ingredients. An abu...
2017 Invention Methods and compositions for deterring abuse. Effective methods and compositions to deter abuse o...
2016 Invention Methods and compositions for regulating conversion of a prodrug to an active pharmaceutical ingre...
2014 P/S Pharmaceutical preparations, namely, immediate-release oxycodone hydrochloride for pain relief in...
Invention Abuse deterrent compositions and methods of making same. This invention relates a therapeutic pha...
Invention Methods and compositions for deterring abuse. A therapeutic composition comprising: a methampheta...
Invention Methods and compositions for deterring abuse. A therapeutic composition comprising: a methamphet...
2013 Invention Self-regulated release of active pharmaceutical ingredient. An abuse deterrent pharmaceutical com...
Invention Stabilization of one-pot methamphetamine synthesis systems. Methods and compositions for stabili...
Invention Stabilization of one-pot methamphetamine synthesis systems. Methods and compositions for stabiliz...
2012 Invention Methods and compositions for deterring abuse of orally administered pharmaceutical products. Thi...
2011 Invention Extended release opioid abuse deterrent compositions and methods of making same. This invention r...
Invention Optimized niacin compositions in pharmaceutical products. The present invention includes composi...
Invention Optimized niacin compositions in pharmaceutical products. The present invention includes composit...
P/S Pharmaceutical preparations, namely, oral medications containing pseudoephedrine hydrochloride fo...
2010 Invention Pharmaceutical compositions for deterring misuse, abuse, and diversion. Pharmaceutical compositi...
Invention Pharmaceutical compositions for deterring misuse, abuse, and diversion. Pharmaceutical compositio...
2008 P/S Prescription pharmaceuticals, namely, an analgesic for human use
Invention Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms there...
P/S Pharmaceutical research and development services.
2007 Invention Methods and compositions for deterring abuse of orally administered pharmaceutical products. This...
Invention Methods and compositions for deterring abuse of opioid containing dosage forms. This invention re...
2005 Invention Production of opioid analgesics. The present invention includes a process for the manufacture of ...
2004 P/S Pharmaceutical research and development services
P/S Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possi...